Thallium-201SPECT assessment in the detection of recurrences of treated gliomas and ependymomas

Clinical and Translational Oncology

Volumn 8, Issue 10, 2006, Pages 750-754

  Caresia, Ana Paula ^a   Castell Conesa, Joan ^a   Negre, Montserrat ^a   Mestre, Antoni ^a   Cuberas, Gemma ^a   Mañes, Anabel ^a   Maldonado, Xavier ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Brain SPECT; Malignant brain neoplasm; Radiation therapy; Recurrence; Thallium

Indexed keywords

THALLIUM 201; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; THALLIUM;

ADULT; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; EPENDYMOMA; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NON INVASIVE MEASUREMENT; OVERALL SURVIVAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN TUMOR; COMPARATIVE STUDY; LABORATORY DIAGNOSIS; MIDDLE AGED; MORTALITY; PROGNOSIS; RADIATION DOSE; SCINTISCANNING; STATISTICAL ANALYSIS; SURVIVAL; TIME; TUMOR RECURRENCE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; DATA INTERPRETATION, STATISTICAL; EPENDYMOMA; FALSE NEGATIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY DOSAGE; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; THALLIUM RADIOISOTOPES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 39049180950     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-006-0122-9     Document Type: Article

References (18)

1. Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro-oncol. 2006;8:27-37.
2. Bernard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med. 2003;33:148-62.
3. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: An interim analysis. Int J Radiat Oncol Biol Phys. 2002;52:316-24.
4. Stupp R, Mason WP, Van den Bent MJ, et al. European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-96.
5. 201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma. J Clin Oncol. 2003;21:3559-65.
6. 201Tl SPECT and CT in the follow-up of irradiated brain tumors. Int J Clin Oncol. 2004;9:51-8.
7. 201Tl SPET in the differential diagnosis of brain tumours. Nucl Med Commun. 1999;20:637-45.
8. 201 SPECT Compared with Histopathologic Grade in the Prognostic Assessment of Cerebral Gliomas. Clin Nucl Med. 2001;26:119-24.
9. 201Tl. Neuroradiology. 2001;43:1023-30.
10. 201-SPECT in typing of brain space occupying lesions] Rev Esp Med Nucl. 2004;23:330-7.
11. Matheja P, Rickert C, Weckesser M, et al. Sequential scintigraphic strategy for the differentiation of brain tumours. Eur J Nucl Med. 2000;27:550-8.
12. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma. J Nucl Med. 2004;45:409-13.
13. 201Tl SPECT imaging of brain tumors. J Nucl Med. 2000;41:5-10.
14. 201 uptake and retention indices for evaluation of brain lesions with SPECT. J Clin Neurosci. 2002;9:653-8.
15. 201 SPECT: The optimal prediction of response in glioma therapy. Eur J Nucl Med Mol Imaging. 2006;33:222-7.
16. 18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours. Eur J Nucl Med. 1998;25:1261-9.
17. Brunetti A, Alfano B, Soricelli A, et al. Functional characterization of brain tumors: An overview of the potential clinical value. Nucl Med Biol. 1996;23:699-715.
18. 11C-methionine PET in suspected recurrence of glioma: Sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging. 2005;32:39-51.